首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Breast cancer-targets and therapy

缩写:

ISSN:1179-1314

e-ISSN:1179-1314

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引617
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yanjia Fan,Yudi Jin,Cheng Tian et al. Yanjia Fan et al.
Background: Lymph node (LN) status is a critical prognostic factor for breast cancer patients undergoing neoadjuvant chemotherapy (NAC). This study aims to develop and validate machine learning models to predict LN respon...
Yuxin Yan,Yizi Jin,Mingxi Lin et al. Yuxin Yan et al.
Background: Limited real-world data are available on the effectiveness and safety of trastuzumab deruxtecan (T-DXd, DS8201a) in patients with HER2-positive and HER2-low metastatic breast cancer (MBC), particularly within ...
Yongqu Lu,Lehao Ren,Meng Yang et al. Yongqu Lu et al.
Despite substantial progress in the diagnosis and treatment of breast cancer, current therapeutic regimens exhibit limitations, necessitating the identification of more robust biomarkers to optimize personalized strategies. Circulating tumo...
Jie Yuan,Fei Xin,Ruliang Wang Jie Yuan
Background: Bone metastasis affects nearly 70% of patients with advanced breast cancer, significantly influencing patient survival. Osteoclasts play a crucial role in osteolysis and the proliferation of bone tumor cell me...
Jiafang Xu,Jincha Long,Zhen Ying Li et al. Jiafang Xu et al.
Objective: To explore the effects of Clinacanthus nutans extract (CnE) on triple-negative breast cancer (TNBC) and mechanism of action. Methods: ...
Fernanda M Orduña-Medina,Lorena Díaz de León-Martinez,Grecia D D Alarcón-Rivera et al. Fernanda M Orduña-Medina et al.
Breast cancer is a leading cause of mortality in women worldwide, primarily due to challenges in early detection and limited access to timely treatment. While mammography is widely used, it may produce false positives and lead to overdiagno...
Xingchao Xu,XiangQi Li Xingchao Xu
Modern Western medicine uses surgeries, chemotherapy, targeted therapy, and radiotherapy to inhibit breast cancer cells through pathways such as apoptosis, necrosis, and autophagy. However, for triple-negative breast cancer (TNBC), a highly...
Kun Zhang,Shijie Wu,Yunxiang Zhou et al. Kun Zhang et al.
Purpose: Thrombocytopenia is a common adverse event associated with trastuzumab emtansine (T-DM1) treatment in patients with HER2-positive metastatic breast cancer. This study aims to evaluate the incidence, clinical char...